KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Current Liabilities (2016 - 2025)

Medpace Holdings' Total Current Liabilities history spans 11 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 21.66% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, up 21.66%, while the annual FY2025 figure was $1.3 billion, 21.66% up from the prior year.
  • Total Current Liabilities reached $1.3 billion in Q4 2025 per MEDP's latest filing, up from $1.3 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.3 billion in Q4 2025 to a low of $447.3 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $882.6 million, with a median of $880.4 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: surged 85.98% in 2022, then decreased 3.02% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $557.2 million in 2021, then soared by 44.19% to $803.5 million in 2022, then grew by 15.14% to $925.1 million in 2023, then rose by 19.39% to $1.1 billion in 2024, then rose by 21.66% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Total Current Liabilities are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.2 billion (Q2 2025).